107 related articles for article (PubMed ID: 22350135)
41. Creatine supplementation does not augment muscle carnosine content in type 2 diabetic patients.
Gualano B; Lugaresi R; de Salles Painelli V; Queiroz AC; Artioli G; Roschel H; Otaduy MC; Leite Cda C; Lancha AH
Appl Physiol Nutr Metab; 2011 Oct; 36(5):764-7. PubMed ID: 21999299
[TBL] [Abstract][Full Text] [Related]
42. Skeletal muscle lipase content and activity in obesity and type 2 diabetes.
Jocken JW; Moro C; Goossens GH; Hansen D; Mairal A; Hesselink MK; Langin D; van Loon LJ; Blaak EE
J Clin Endocrinol Metab; 2010 Dec; 95(12):5449-53. PubMed ID: 20843949
[TBL] [Abstract][Full Text] [Related]
43. Muscle ceramide content in man is higher in type I than type II fibers and not influenced by glycogen content.
Nordby P; Prats C; Kristensen D; Ekroos K; Forsberg G; Andersen JL; Ploug T; Dela F; Storlien L; Helge JW
Eur J Appl Physiol; 2010 Jul; 109(5):935-43. PubMed ID: 20309708
[TBL] [Abstract][Full Text] [Related]
44. Effect of short-term exercise training on intramyocellular lipid content.
Bajpeyi S; Reed MA; Molskness S; Newton C; Tanner CJ; McCartney JS; Houmard JA
Appl Physiol Nutr Metab; 2012 Oct; 37(5):822-8. PubMed ID: 22691059
[TBL] [Abstract][Full Text] [Related]
45. Insulin treatment increases skeletal muscle fibre area in patients with diabetes mellitus type 2.
Cederholm T; Sylvén C; Esbjörnsson-Liljedahl M; Jansson E
Clin Physiol; 2000 Sep; 20(5):354-9. PubMed ID: 10971546
[TBL] [Abstract][Full Text] [Related]
46. Lipid in skeletal muscle myotubes is associated to the donors' insulin sensitivity and physical activity phenotypes.
Bajpeyi S; Myrland CK; Covington JD; Obanda D; Cefalu WT; Smith SR; Rustan AC; Ravussin E
Obesity (Silver Spring); 2014 Feb; 22(2):426-34. PubMed ID: 23818429
[TBL] [Abstract][Full Text] [Related]
47. Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans.
Hickey MS; Carey JO; Azevedo JL; Houmard JA; Pories WJ; Israel RG; Dohm GL
Am J Physiol; 1995 Mar; 268(3 Pt 1):E453-7. PubMed ID: 7900793
[TBL] [Abstract][Full Text] [Related]
48. DNA methylation is altered in B and NK lymphocytes in obese and type 2 diabetic human.
Simar D; Versteyhe S; Donkin I; Liu J; Hesson L; Nylander V; Fossum A; Barrès R
Metabolism; 2014 Sep; 63(9):1188-97. PubMed ID: 24996265
[TBL] [Abstract][Full Text] [Related]
49. Are substrate use during exercise and mitochondrial respiratory capacity decreased in arm and leg muscle in type 2 diabetes?
Larsen S; Ara I; Rabøl R; Andersen JL; Boushel R; Dela F; Helge JW
Diabetologia; 2009 Jul; 52(7):1400-8. PubMed ID: 19396425
[TBL] [Abstract][Full Text] [Related]
50. Insulin resistance induced by de novo pathway-generated C16-ceramide is associated with type 2 diabetes in an obese population.
Chathoth S; Ismail MH; Alghamdi HM; Zakaria HM; Hassan KA; Alshomimi S; Vatte C; Cyrus C; Alsaif HS; Mostafa A; Shaaban H; Al Ali A
Lipids Health Dis; 2022 Feb; 21(1):24. PubMed ID: 35184720
[TBL] [Abstract][Full Text] [Related]
51. Evidence of an increased number of type IIb muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM.
Nyholm B; Qu Z; Kaal A; Pedersen SB; Gravholt CH; Andersen JL; Saltin B; Schmitz O
Diabetes; 1997 Nov; 46(11):1822-8. PubMed ID: 9356032
[TBL] [Abstract][Full Text] [Related]
52. Role of Ceramide in Apoptosis and Development of Insulin Resistance.
Kuzmenko DI; Klimentyeva TK
Biochemistry (Mosc); 2016 Sep; 81(9):913-27. PubMed ID: 27682164
[TBL] [Abstract][Full Text] [Related]
53. Satellite cells in human skeletal muscle; from birth to old age.
Verdijk LB; Snijders T; Drost M; Delhaas T; Kadi F; van Loon LJ
Age (Dordr); 2014 Apr; 36(2):545-7. PubMed ID: 24122288
[TBL] [Abstract][Full Text] [Related]
54. Training Does Not Alter Muscle Ceramide and Diacylglycerol in Offsprings of Type 2 Diabetic Patients Despite Improved Insulin Sensitivity.
Søgaard D; Østergård T; Blachnio-Zabielska AU; Baranowski M; Vigelsø AH; Andersen JL; Dela F; Helge JW
J Diabetes Res; 2016; 2016():2372741. PubMed ID: 27777958
[TBL] [Abstract][Full Text] [Related]
55. Targeting ceramide metabolism in obesity.
Aburasayn H; Al Batran R; Ussher JR
Am J Physiol Endocrinol Metab; 2016 Aug; 311(2):E423-35. PubMed ID: 27382035
[TBL] [Abstract][Full Text] [Related]
56. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance.
Haus JM; Kashyap SR; Kasumov T; Zhang R; Kelly KR; Defronzo RA; Kirwan JP
Diabetes; 2009 Feb; 58(2):337-43. PubMed ID: 19008343
[TBL] [Abstract][Full Text] [Related]
57. Is there a skeletal muscle mass threshold associated with the deterioration of insulin sensitivity in sedentary lean to obese postmenopausal women?
Barsalani R; Brochu M; Dionne IJ
Diabetes Res Clin Pract; 2013 Nov; 102(2):123-8. PubMed ID: 24120357
[TBL] [Abstract][Full Text] [Related]
58. Effects of meal ingestion on intramyocellular ceramide concentrations and fractional de novo synthesis in humans.
Chung JO; Koutsari C; Blachnio-Zabielska AU; Hames KC; Jensen MD
Am J Physiol Endocrinol Metab; 2018 Feb; 314(2):E105-E114. PubMed ID: 28970356
[TBL] [Abstract][Full Text] [Related]
59. Reduced skeletal muscle oxidative capacity and elevated ceramide but not diacylglycerol content in severe obesity.
Coen PM; Hames KC; Leachman EM; DeLany JP; Ritov VB; Menshikova EV; Dubé JJ; Stefanovic-Racic M; Toledo FG; Goodpaster BH
Obesity (Silver Spring); 2013 Nov; 21(11):2362-71. PubMed ID: 23512750
[TBL] [Abstract][Full Text] [Related]
60. Myocardium of type 2 diabetic and obese patients is characterized by alterations in sphingolipid metabolic enzymes but not by accumulation of ceramide.
Baranowski M; Blachnio-Zabielska A; Hirnle T; Harasiuk D; Matlak K; Knapp M; Zabielski P; Gorski J
J Lipid Res; 2010 Jan; 51(1):74-80. PubMed ID: 19617631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
